Attomarker

Attomarker is a developer of point-of-care multiplex diagnostic devices using proprietary gold nanoparticle nanophotonic technology.

Its platform measures up to 20 biomarkers simultaneously from a single finger-prick blood sample, delivering quantitative results within minutes.

Tests are UKCA-marked and in clinical use, with current commercial focus on immune profiling in Long COVID patients.

The pipeline spans food allergy, obesity, infectious disease, and antimicrobial resistance applications, targeting primary care, specialist clinics, and consumer settings.